Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
FORM 4
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
Cigna operates a diversified health services business combining traditional health insurance with Evernorth, a large pharmacy benefit management and health services segment that has become an increasingly important growth driver.
Business model
The company earns premium revenue from health insurance products along with fee revenue from its Evernorth pharmacy benefit management and specialty pharmacy services, providing diversification beyond core insurance underwriting.
Growth drivers
- Evernorth pharmacy benefit management and specialty pharmacy growth
- Health insurance membership growth in commercial and government programs
- Medical cost management improvements
- International health insurance expansion
Competitive position
Cigna's combination of health insurance and pharmacy benefit management through Evernorth gives it scale and diversification advantages relative to insurers without a comparable pharmacy services business.
Risks
Medical cost trend increases can pressure insurance margins, pharmacy benefit management faces ongoing regulatory scrutiny regarding drug pricing practices, and competition across both insurance and pharmacy services segments remains intense.
Valuation
Cigna trades at a moderate multiple typical of diversified health services companies, with Evernorth's growth profile providing some differentiation relative to pure health insurers.
Final view
Cigna's diversification through Evernorth provides a differentiated growth profile beyond core health insurance underwriting. My view is neutral to favorable, with medical cost trends and pharmacy benefit management regulatory developments being key factors to monitor.
Overall rating: 65/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.